Parker, Special Agent in Charge of the Office of Personnel Management’s Office of Inspector General. “Submitting claims for medically unnecessary tests threatens the integrity of the federal health care programs and wastes taxpayer dollars,” said Amy K. Attorney’s Office and our law enforcement partners to hold wrongdoers accountable.” “Submitting claims for medically unnecessary services will not be tolerated, and the VA OIG will continue to work with the U.S. “Companies that provide services to VA will be held to the highest standards of integrity, professionalism, and accountability,” said Christopher Algieri, Special Agent in Charge of the Veteran Affairs’ Office of Inspector General’s Northeast Field Office. We are committed to pursuing these types of allegations along with our law enforcement partners as we work to protect the integrity of our federal health care system.” “When that obligation is violated, government health care programs – and American taxpayers – pay the price. Department of Health and Human Services, Office of Inspector General. “Clinical laboratories are expected to closely follow Medicare rules and bill properly - nothing more, nothing less,” said Special Agent in Charge Phillip M. Companies that engage in this fraudulent conduct will be held accountable.” “Prioritizing profit over complying with the law wastes hard earned taxpayer dollars. “Laboratories that bill for medically unnecessary tests drain funds from Medicare and other federally funded health care programs,” said United States Attorney Rachael S. Inform submitted these medically unnecessary tests for payment, causing federal health care programs to pay for false claims. The United States contends that Inform’s policy of conducting routine additional tests caused Inform to perform many tests that were medically unnecessary. On April 27, 2022, Fulgent Genetics purchased Inform, and the company is now a wholly owned subsidiary of Fulgent Genetics.Īccording to the settlement, Inform admits that, between 20, it routinely and automatically conducted additional tests on biopsy specimens prior to a pathologist’s review and without an individualized determination regarding whether additional tests were medically necessary. Inform is a clinical laboratory headquartered in Irving, Texas, that provides anatomic pathology services to physician practices throughout the United States. (Inform), has agreed to pay $16 million to resolve allegations that it submitted false claims for payment to Medicare and other federal health care programs. BOSTON – Inform Diagnostics, Inc., (Inform) formerly known as Miraca Life Sciences, Inc.
0 kommentar(er)
